{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:30:25Z","timestamp":1786984225413,"version":"build-2736575974"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY20H090021"],"award-info":[{"award-number":["LY20H090021"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ajp.2024.104246","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T21:22:19Z","timestamp":1726780939000},"page":"104246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Therapeutic potential of ketamine in management of epilepsy: Clinical implications and mechanistic insights"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7313-4067","authenticated-orcid":false,"given":"Yunfei","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajp.2024.104246_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/NDT.S2937","article-title":"Levetiracetam in the treatment of epilepsy","volume":"4","author":"Abou-Khalil","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1503\/jpn.160175","article-title":"Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism","volume":"42","author":"Aleksandrova","year":"2017","journal-title":"J. Psychiatry Neurosci."},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41467-019-13809-8","article-title":"Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines","volume":"11","author":"Ali","year":"2020","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.ajp.2024.104246_bib4","doi-asserted-by":"crossref","first-page":"e2286","DOI":"10.1212\/WNL.0000000000010611","article-title":"Ketamine to treat super-refractory status epilepticus","volume":"95","author":"Alkhachroum","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ajp.2024.104246_bib5","doi-asserted-by":"crossref","DOI":"10.15190\/d.2020.7","article-title":"Epileptic seizures","volume":"8","author":"Anwar","year":"2020","journal-title":"Discoveries"},{"issue":"5","key":"10.1016\/j.ajp.2024.104246_bib6","article-title":"Lacosamide add-on therapy for focal epilepsy","volume":"5","author":"Babar","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00023210-200418010-00006","article-title":"Spotlight on oxcarbazepine in epilepsy","volume":"18","author":"Bang","year":"2004","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib8","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1213\/ANE.0000000000001856","article-title":"In Vogue: ketamine for neuroprotection in acute neurologic Injury","volume":"124","author":"Bell","year":"2017","journal-title":"Anesth. Analg."},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2004.09.005","article-title":"Efficacy and safety of levetiracetam 1000-3000 mg\/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study","volume":"63","author":"Beran","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ajp.2024.104246_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0079-6123(05)50020-7","article-title":"Consciousness and epilepsy: why are patients with absence seizures absent?","volume":"150","author":"Blumenfeld","year":"2005","journal-title":"Prog. Brain Res."},{"issue":"3","key":"10.1016\/j.ajp.2024.104246_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0028-3908(03)00203-X","article-title":"Effects of etomidate, ketamine or propofol, and their combinations with conventional antiepileptic drugs on amygdala-kindled convulsions in rats","volume":"45","author":"Borowicz","year":"2003","journal-title":"Neuropharmacology"},{"issue":"2-3","key":"10.1016\/j.ajp.2024.104246_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-1211(00)00175-3","article-title":"Ketamine controls prolonged status epilepticus","volume":"42","author":"Borris","year":"2000","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1016\/j.ajp.2024.104246_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41397-019-0120-2","article-title":"Ketamine in seizure management and future pharmacogenomic considerations","volume":"20","author":"Borsato","year":"2020","journal-title":"Pharmacogenom. J."},{"issue":"9","key":"10.1016\/j.ajp.2024.104246_bib14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0031-6989(83)80089-7","article-title":"Effect of ketamine enantiomers on sound-induced convulsions in epilepsy prone rats","volume":"15","author":"Bourn","year":"1983","journal-title":"Pharm. Res. Commun."},{"key":"10.1016\/j.ajp.2024.104246_bib15","unstructured":"Bromfield Eb, C.J., Sirven J.I., Eds. (2006). An Introduction to Epilepsy (Internet). West Hartford (CT): American Epilepsy Society. Basic Mechanisms Underlying Seizures and Epilepsy, Chapter 1."},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/epi.17550","article-title":"Ketamine as advanced second-line treatment in benzodiazepine-refractory convulsive status epilepticus in children","volume":"64","author":"Buratti","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.ajp.2024.104246_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.107602","article-title":"Is depression in patients with temporal lobe epilepsy related to hippocampal sclerosis? A meta-analysis","volume":"225","author":"Cai","year":"2023","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"6","key":"10.1016\/j.ajp.2024.104246_bib18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/ane.13610","article-title":"Ketamine in adult super-refractory status epilepticus: efficacy analysis on a prospective registry","volume":"145","author":"Caranzano","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ajp.2024.104246_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.934507","article-title":"Stem cell therapy in treating epilepsy","volume":"16","author":"Chang","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ajp.2024.104246_bib20","article-title":"Roles of N-methyl-D-aspartate receptors (NMDARs) in epilepsy","volume":"14","author":"Chen","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ajp.2024.104246_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.seizure.2021.07.005","article-title":"Association between autoimmune encephalitis and epilepsy: Systematic review and meta-analysis","volume":"91","author":"Chen","year":"2021","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.ajp.2024.104246_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41594-022-00772-0","article-title":"Structural insights into binding of therapeutic channel blockers in NMDA receptors","volume":"29","author":"Chou","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ajp.2024.104246_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.672526","article-title":"Ketamine: neuroprotective or neurotoxic?","volume":"15","author":"Choudhury","year":"2021","journal-title":"Front. Neurosci."},{"issue":"8","key":"10.1016\/j.ajp.2024.104246_bib24","first-page":"1717","article-title":"Brain network correlates of epilepsy occurrence in multiple sclerosis and neuroinflammation","volume":"18","author":"Ciolac","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"10","key":"10.1016\/j.ajp.2024.104246_bib25","first-page":"Cd003196","article-title":"Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder","volume":"2013","author":"Cipriani","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajp.2024.104246_bib26","unstructured":"John P. Cunha D., FACOEP. (2023). ZONEGRAN. \u3008https:\/\/www.rxlist.com\/zonegran-drug.htm\u3009."},{"key":"10.1016\/j.ajp.2024.104246_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107740","article-title":"Ambulatory care for epilepsy via telemedicine during the COVID-19 pandemic","volume":"116","author":"Datta","year":"2021","journal-title":"Epilepsy Behav."},{"issue":"18","key":"10.1016\/j.ajp.2024.104246_bib28","doi-asserted-by":"crossref","first-page":"e2261","DOI":"10.1212\/WNL.0000000000011846","article-title":"Network-related changes in neurotransmitters and seizure propagation during rodent epileptogenesis","volume":"96","author":"Dhaher","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.ajp.2024.104246_bib29","unstructured":"Drugs.com. (2021a). Diazepam Dosage. \u3008https:\/\/www.drugs.com\/dosage\/diazepam.html\u3009."},{"key":"10.1016\/j.ajp.2024.104246_bib30","unstructured":"Drugs.com. (2021b). Lamotrigine Tablets Prescribing Information. \u3008https:\/\/www.drugs.com\/pro\/lamotrigine-tablets.html\u3009."},{"key":"10.1016\/j.ajp.2024.104246_bib31","unstructured":"Drugs.com. (2021c). Topiramate Prescribing Information. \u3008https:\/\/www.drugs.com\/pro\/topiramate.html\u3009."},{"key":"10.1016\/j.ajp.2024.104246_bib32","unstructured":"Drugs.com. (2022a). Carbamazepine Dosage. \u3008https:\/\/www.drugs.com\/dosage\/carbamazepine.html\u3009."},{"key":"10.1016\/j.ajp.2024.104246_bib33","unstructured":"Drugs.com. (2022b). Ethosuximide use while Breastfeeding. \u3008https:\/\/www.drugs.com\/breastfeeding\/ethosuximide.html\u3009."},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib34","first-page":"162","article-title":"The effect of lamotrigine on epilepsy","volume":"11","author":"Ebrahimi","year":"2012","journal-title":"Iran. J. Neurol."},{"issue":"5","key":"10.1016\/j.ajp.2024.104246_bib35","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002308RR","article-title":"Slack K(+) channels attenuate NMDA-induced excitotoxic brain damage and neuronal cell death","volume":"35","author":"Ehinger","year":"2021","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.ajp.2024.104246_bib36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/YCT.0000000000000225","article-title":"Effect of the addition of ketamine to sevoflurane anesthesia on seizure duration in electroconvulsive therapy","volume":"31","author":"Erdil","year":"2015","journal-title":"J. ECT"},{"key":"10.1016\/j.ajp.2024.104246_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2015.05.010","article-title":"Ketamine for the treatment of refractory status epilepticus","volume":"30","author":"Fang","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.ajp.2024.104246_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.674483","article-title":"The pharmacoresistant epilepsy: an overview on existant and new emerging therapies","volume":"12","author":"Fattorusso","year":"2021","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.ajp.2024.104246_bib39","first-page":"811","article-title":"Topiramate in the treatment of partial and generalized epilepsy","volume":"3","author":"Faught","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ajp.2024.104246_bib40","unstructured":"FDA. (2019). New Drug Therapy Approvals 2019."},{"issue":"10","key":"10.1016\/j.ajp.2024.104246_bib41","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00415-020-09926-w","article-title":"A review of seizures and epilepsy following traumatic brain injury","volume":"267","author":"Fordington","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.ajp.2024.104246_bib42","unstructured":"Foundation E. (2023a). Lacosamide. \u3008https:\/\/www.epilepsy.com\/tools-resources\/seizure-medication-list\/lacosamide\u3009."},{"key":"10.1016\/j.ajp.2024.104246_bib43","unstructured":"Foundation E. (2023b). Oxcarbazepine. \u3008https:\/\/www.epilepsy.com\/tools-resources\/seizure-medication-list\/oxcarbazepine\u3009."},{"issue":"2","key":"10.1016\/j.ajp.2024.104246_bib44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/1566524015666150303003028","article-title":"Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders","volume":"15","author":"Gao","year":"2015","journal-title":"Curr. Mol. Med."},{"issue":"8","key":"10.1016\/j.ajp.2024.104246_bib45","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/epi.12247","article-title":"Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study","volume":"54","author":"Gaspard","year":"2013","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ajp.2024.104246_bib46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0404.2009.01218.x","article-title":"Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures","volume":"120","author":"Gil-Nagel","year":"2009","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/vec.12956","article-title":"Ketamine-dexmedetomidine combination and controlled mild hypothermia for the treatment of long-lasting and super-refractory status epilepticus in 3 dogs suffering from idiopathic epilepsy","volume":"30","author":"Gioeni","year":"2020","journal-title":"J. Vet. Emerg. Crit. Care"},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/epi.12028","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"issue":"25","key":"10.1016\/j.ajp.2024.104246_bib49","doi-asserted-by":"crossref","first-page":"14503","DOI":"10.1073\/pnas.1922563117","article-title":"Nanoscale co-organization and coactivation of AMPAR, NMDAR, and mGluR at excitatory synapses","volume":"117","author":"Goncalves","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajp.2024.104246_bib50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eplepsyres.2019.04.008","article-title":"Effects of ketamine on EEG in baboons with genetic generalized epilepsy","volume":"154","author":"Gowda","year":"2019","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ajp.2024.104246_bib51","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/B978-0-444-52899-5.00045-9","article-title":"Metabolic and degenerative disorders","volume":"108","author":"Granata","year":"2012","journal-title":"Handb. Clin. Neurol."},{"issue":"22","key":"10.1016\/j.ajp.2024.104246_bib52","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1523\/JNEUROSCI.3270-17.2018","article-title":"Short-term plasticity combines with excitation-inhibition balance to expand cerebellar purkinje cell dynamic range","volume":"38","author":"Grangeray-Vilmint","year":"2018","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.ajp.2024.104246_bib53","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1152\/jn.00494.2015","article-title":"Ca2+ removal by the plasma membrane Ca2+-ATPase influences the contribution of mitochondria to activity-dependent Ca2+ dynamics in Aplysia neuroendocrine cells","volume":"115","author":"Groten","year":"2016","journal-title":"J. Neurophysiol."},{"issue":"10","key":"10.1016\/j.ajp.2024.104246_bib54","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.ajp.2024.104246_bib55","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1038\/s41380-022-01546-2","article-title":"Comments to \"Fluvoxamine and long COVID-19: a new role for sigma-1 receptor (S1R) agonists\" by Khani and Entezari-Maleki","volume":"27","author":"Hashimoto","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104246_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109171","article-title":"Ketamine; history and role in anesthetic pharmacology","volume":"216","author":"Hirota","year":"2022","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.ajp.2024.104246_bib57","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40263-016-0371-2","article-title":"(S)-Ketamine in refractory and super-refractory status epilepticus: a retrospective study","volume":"30","author":"H\u00f6fler","year":"2016","journal-title":"CNS Drugs"},{"issue":"16","key":"10.1016\/j.ajp.2024.104246_bib58","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/bioinformatics\/btx225","article-title":"Mapping genes for calcium signaling and their associated human genetic disorders","volume":"33","author":"H\u00f6rtenhuber","year":"2017","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.ajp.2024.104246_bib59","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1007\/s12035-020-01871-z","article-title":"Magnesium acts as a second messenger in the regulation of NMDA receptor-mediated CREB signaling in neurons","volume":"57","author":"Hou","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ajp.2024.104246_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109272","article-title":"Depression and antidepressant effects of ketamine and its metabolites: the pivotal role of gut microbiota","volume":"220","author":"Hua","year":"2022","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib61","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/s41467-018-04439-7","article-title":"The CaMKII\/NMDA receptor complex controls hippocampal synaptic transmission by kinase-dependent and independent mechanisms","volume":"9","author":"Incontro","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.ajp.2024.104246_bib62","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ijnp\/pyab010","article-title":"Repeated but not single administration of ketamine prolongs increases of the firing activity of norepinephrine and dopamine neurons","volume":"24","author":"Iro","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.ajp.2024.104246_bib63","doi-asserted-by":"crossref","first-page":"e1227","DOI":"10.1212\/WNL.0000000000200889","article-title":"Ketamine for management of neonatal and pediatric refractory status epilepticus","volume":"99","author":"Jacobwitz","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.ajp.2024.104246_bib64","article-title":"A comparison of ketamine and midazolam as first-line anesthetic infusions for pediatric status epilepticus","author":"Jacobwitz","year":"2023","journal-title":"Neurocrit. Care"},{"issue":"9","key":"10.1016\/j.ajp.2024.104246_bib65","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1474-4422(16)30127-2","article-title":"Surgical treatment for epilepsy: the potential gap between evidence and practice","volume":"15","author":"Jett\u00e9","year":"2016","journal-title":"Lancet Neurol."},{"issue":"13","key":"10.1016\/j.ajp.2024.104246_bib66","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jama.2022.3880","article-title":"Antiseizure medications for adults with epilepsy: a review","volume":"327","author":"Kanner","year":"2022","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ajp.2024.104246_bib67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/15357597221141274","article-title":"Money matters: measuring the economic impact of epilepsy","volume":"23","author":"Karakis","year":"2023","journal-title":"Epilepsy Curr."},{"issue":"7","key":"10.1016\/j.ajp.2024.104246_bib68","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/0883073817698629","article-title":"Increasing ketamine use for refractory status epilepticus in US Pediatric Hospitals","volume":"32","author":"Keros","year":"2017","journal-title":"J. Child Neurol."},{"issue":"9","key":"10.1016\/j.ajp.2024.104246_bib69","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40263-022-00940-2","article-title":"Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability","volume":"36","author":"Kienitz","year":"2022","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib70","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.14336\/AD.2021.0302","article-title":"Super-refractory status epilepticus: prognosis and recent advances in management","volume":"12","author":"Kirmani","year":"2021","journal-title":"Aging Dis."},{"key":"10.1016\/j.ajp.2024.104246_bib71","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.schres.2017.06.027","article-title":"Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia","volume":"193","author":"Koh","year":"2018","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.ajp.2024.104246_bib72","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0091-3057(96)00221-3","article-title":"Blockade of morphine-induced hindlimb myoclonic seizures in mice by ketamine","volume":"56","author":"Kolesnikov","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib73","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41398-019-0460-3","article-title":"Prognosis and improved outcomes in major depression: a review","volume":"9","author":"Kraus","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1176\/jnp.15.1.27","article-title":"Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT","volume":"15","author":"Krystal","year":"2003","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13181-017-0626-4","article-title":"The pharmacology and toxicology of third-generation anticonvulsant drugs","volume":"13","author":"Lapenna","year":"2017","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.ajp.2024.104246_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.109056","article-title":"Cognitive behavior therapy for depression in people with epilepsy: a systematic review and meta-analysis","volume":"138","author":"Li","year":"2023","journal-title":"Epilepsy Behav."},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib77","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajhg.2016.07.013","article-title":"GRIN2D Recurrent De Novo dominant mutation causes a severe epileptic encephalopathy treatable with NMDA receptor channel blockers","volume":"99","author":"Li","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib78","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/epi4.12070","article-title":"Neurostimulation as a promising epilepsy therapy","volume":"2","author":"Lin","year":"2017","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.ajp.2024.104246_bib79","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fncel.2017.00181","article-title":"Glutamate deregulation in ketamine-induced psychosis-a potential role of PSD95, NMDA receptor and PMCA interaction","volume":"11","author":"Lisek","year":"2017","journal-title":"Front. Cell Neurosci."},{"issue":"21","key":"10.1016\/j.ajp.2024.104246_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218410","article-title":"Ketamine and calcium signaling-a crosstalk for neuronal physiology and pathology","volume":"21","author":"Lisek","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ajp.2024.104246_bib81","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ajp.2024.104246_bib82","doi-asserted-by":"crossref","unstructured":"Lozano, J.M.R. (2017). Congenital malformations in children of epileptic mothers with intrauterine exposures to antiepileptic drugs and comparison with a control group. Update from Pinar del Rio Epilepsy Pregnancy Multicenter Study, Experience 1996\u20132016. (P6.237). Neurology, 88(16 Supplement), P6.237.","DOI":"10.1212\/WNL.88.16_supplement.P6.237"},{"key":"10.1016\/j.ajp.2024.104246_bib83","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.wneu.2022.07.141","article-title":"Combined responsive neurostimulation and focal resection for super refractory status epilepticus: a systematic review and illustrative case report","volume":"167","author":"Mamaril-Davis","year":"2022","journal-title":"World Neurosurg."},{"key":"10.1016\/j.ajp.2024.104246_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107229","article-title":"Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice","volume":"111","author":"Marrero-Rosado","year":"2020","journal-title":"Epilepsy Behav."},{"issue":"37","key":"10.1016\/j.ajp.2024.104246_bib85","article-title":"A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs","volume":"11","author":"Marson","year":"2007","journal-title":"SANAD Trial Health Technol. Assess."},{"key":"10.1016\/j.ajp.2024.104246_bib86","article-title":"Ketogenic diet and other dietary treatments for epilepsy","volume":"2","author":"Martin","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib87","doi-asserted-by":"crossref","first-page":"401","DOI":"10.5811\/cpcem.2019.9.44271","article-title":"Ketamine implicated in new onset seizure","volume":"3","author":"Meaden","year":"2019","journal-title":"Clin. Pract. Cases Emerg. Med."},{"key":"10.1016\/j.ajp.2024.104246_bib88","unstructured":"Medscape. Eslicarbazepine acetate (Rx). \u3008https:\/\/reference.medscape.com\/drug\/aptiom-eslicarbazepine-acetate-999902\u3009."},{"key":"10.1016\/j.ajp.2024.104246_bib89","unstructured":"Medscape. Topiramate (Rx). \u3008https:\/\/reference.medscape.com\u3009\/drug\/topamax-trokendi-xr-topiramate-343023."},{"key":"10.1016\/j.ajp.2024.104246_bib90","unstructured":"Medscape. lorazepam (Rx). \u3008https:\/\/reference.medscape.com\/drug\/ativan-loreev-xr-lorazepam-342906\u3009."},{"issue":"7","key":"10.1016\/j.ajp.2024.104246_bib91","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1059-1311(03)00028-1","article-title":"Oral ketamine in paediatric non-convulsive status epilepticus","volume":"12","author":"Mewasingh","year":"2003","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.ajp.2024.104246_bib92","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archneur.1976.00500050008002","article-title":"Clonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures","volume":"33","author":"Mikkelsen","year":"1976","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.ajp.2024.104246_bib93","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/2045-9912.350860","article-title":"Efficacy of ketamine, propofol, and dexmedetomidine for anesthesia in electroconvulsive therapy in treatment-resistant major depressive disorder patients: a double-blind randomized clinical trial","volume":"13","author":"Modir","year":"2023","journal-title":"Med. Gas Res."},{"issue":"971","key":"10.1016\/j.ajp.2024.104246_bib94","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/pgmj.2005.041426","article-title":"Post-stroke seizure and post-stroke epilepsy","volume":"82","author":"Myint","year":"2006","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ajp.2024.104246_bib95","unstructured":"NHS. (2021). Sodium valproate."},{"key":"10.1016\/j.ajp.2024.104246_bib96","unstructured":"NHS. (2022). How and when to take phenytoin. \u3008https:\/\/www.nhs.uk\/medicines\/phenytoin\/how-and-when-to-take-phenytoin\/\u3009."},{"key":"10.1016\/j.ajp.2024.104246_bib97","unstructured":"NHS. (2023). How and when to take clonazepam. \u3008https:\/\/www.nhs.uk\/medicines\/clonazepam\/how-and-when-to-take-clonazepam\/\u3009."},{"key":"10.1016\/j.ajp.2024.104246_bib98","doi-asserted-by":"crossref","unstructured":"NHS 15th annual meeting. 2017. Abstracts Presented at the Neurocritical Care Society (NCS) 15th Annual Meeting. Neurocrit Care, 27(Suppl 2), 1-491.","DOI":"10.1007\/s12028-017-0465-9"},{"issue":"9","key":"10.1016\/j.ajp.2024.104246_bib99","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/epi.13480","article-title":"Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits","volume":"57","author":"Niquet","year":"2016","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.ajp.2024.104246_bib100","article-title":"Calmodulin and amyloid beta as coregulators of critical events during the onset and progression of Alzheimer's Disease","volume":"24","author":"O'day","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ajp.2024.104246_bib101","unstructured":"Organization, W.H. (2023). Epilepsy."},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib102","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00000542-199704000-00021","article-title":"Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors","volume":"86","author":"Orser","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ajp.2024.104246_bib103","doi-asserted-by":"crossref","first-page":"255","DOI":"10.11604\/pamj.2014.18.255.3607","article-title":"Epilepsy and education in developing countries: a survey of school teachers' knowledge about epilepsy and their attitude towards students with epilepsy in Northwestern Nigeria","volume":"18","author":"Owolabi","year":"2014","journal-title":"Pan Afr. Med. J."},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib104","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/pr.117.014456","article-title":"Ion channels in genetic epilepsy: from genes and mechanisms to disease-targeted therapies","volume":"70","author":"Oyrer","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.14581\/jer.19002","article-title":"Antiepileptic drug therapy in patients with drug-resistant epilepsy","volume":"9","author":"Park","year":"2019","journal-title":"J. Epilepsy Res."},{"issue":"9","key":"10.1016\/j.ajp.2024.104246_bib106","article-title":"Understanding seizures and prognosis of the extreme delta brush pattern in anti-N-methyl-D-aspartate (NMDA) receptor encephalitis: a systematic review","volume":"13","author":"Parwani","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.ajp.2024.104246_bib107","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5694\/mja17.00951","article-title":"The management of epilepsy in children and adults","volume":"208","author":"Perucca","year":"2018","journal-title":"Med. J. Aust."},{"issue":"2-3","key":"10.1016\/j.ajp.2024.104246_bib108","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.eplepsyres.2008.08.005","article-title":"Ketamine successfully terminates malignant status epilepticus","volume":"82","author":"Pr\u00fcss","year":"2008","journal-title":"Epilepsy Res."},{"issue":"12","key":"10.1016\/j.ajp.2024.104246_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278907","article-title":"Exploring the association between epilepsy and depression: a systematic review and meta-analysis","volume":"17","author":"Qin","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajp.2024.104246_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115843","article-title":"Clinical efficacy of adjunctive esketamine anesthesia in electroconvulsive therapy for major depressive disorders: a pragmatic, randomized, controlled trial","volume":"335","author":"Ren","year":"2024","journal-title":"Psychiatry Res."},{"issue":"Pt B","key":"10.1016\/j.ajp.2024.104246_bib111","article-title":"GABAergic interneurons in epilepsy: more than a simple change in inhibition","volume":"121","author":"Righes Marafiga","year":"2021","journal-title":"Epilepsy Behav."},{"issue":"10","key":"10.1016\/j.ajp.2024.104246_bib112","first-page":"591","article-title":"Ketamine-NMDA receptor binding structure","volume":"22","author":"Rogers","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.ajp.2024.104246_bib113","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","article-title":"Valproic acid and epilepsy: from molecular mechanisms to clinical evidences","volume":"17","author":"Romoli","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.ajp.2024.104246_bib114","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011565","article-title":"Efficacy of ketamine in refractory convulsive status epilepticus in children: a protocol for a sequential design, multicentre, randomised, controlled, open-label, non-profit trial (KETASER01)","volume":"6","author":"Rosati","year":"2016","journal-title":"BMJ Open"},{"issue":"24","key":"10.1016\/j.ajp.2024.104246_bib115","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1212\/WNL.0b013e318278b685","article-title":"Efficacy and safety of ketamine in refractory status epilepticus in children","volume":"79","author":"Rosati","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ajp.2024.104246_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.547279","article-title":"Intravenous Ketamine Bolus(es) for the treatment of status epilepticus, refractory status epilepticus, and cluster seizures: a retrospective study of 15 dogs","volume":"8","author":"Roynard","year":"2021","journal-title":"Front. Vet. Sci."},{"issue":"3","key":"10.1016\/j.ajp.2024.104246_bib117","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0039-3402005","article-title":"Ketamine infusion for super refractory status epilepticus in alternating hemiplegia of childhood","volume":"51","author":"Samanta","year":"2020","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ajp.2024.104246_bib118","article-title":"Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitis","volume":"12","author":"Santoro","year":"2019","journal-title":"Epilepsy Behav. Rep."},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib119","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11910-007-0053-z","article-title":"The neurobiology of epilepsy","volume":"7","author":"Scharfman","year":"2007","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"4","key":"10.1016\/j.ajp.2024.104246_bib120","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.ajp.2024.104246_bib121","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00109-022-02250-y","article-title":"Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma","volume":"100","author":"Schumacher","year":"2022","journal-title":"J. Mol. Med."},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib122","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s42466-022-00205-9","article-title":"Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication","volume":"4","author":"Seidel","year":"2022","journal-title":"Neurol. Res. Pract."},{"key":"10.1016\/j.ajp.2024.104246_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.868531","article-title":"Gene and cell therapy for epilepsy: a mini review","volume":"15","author":"Shaimardanova","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.ajp.2024.104246_bib124","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.51.6.1765","article-title":"Refractory status epilepticus: response to ketamine","volume":"51","author":"Sheth","year":"1998","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ajp.2024.104246_bib125","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1213\/ANE.0b013e31822747df","article-title":"The toxic effects of s(+)-ketamine on differentiating neurons in vitro as a consequence of suppressed neuronal Ca2+ oscillations","volume":"113","author":"Sinner","year":"2011","journal-title":"Anesth. Analg."},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.18773\/austprescr.2017.005","article-title":"Midazolam for status epilepticus","volume":"40","author":"Smith","year":"2017","journal-title":"Aust Prescr"},{"issue":"2","key":"10.1016\/j.ajp.2024.104246_bib127","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12028-022-01578-0","article-title":"Factors associated with refractory status epilepticus termination following ketamine initiation: a multivariable analysis model","volume":"38","author":"Srinivas","year":"2023","journal-title":"Neurocrit. Care"},{"issue":"6","key":"10.1016\/j.ajp.2024.104246_bib128","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022426","article-title":"Seizures and epilepsy: an overview for neuroscientists","volume":"5","author":"Stafstrom","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"1-2","key":"10.1016\/j.ajp.2024.104246_bib129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2013.01.007","article-title":"Ketamine use in the treatment of refractory status epilepticus","volume":"105","author":"Synowiec","year":"2013","journal-title":"Epilepsy Res"},{"issue":"18","key":"10.1016\/j.ajp.2024.104246_bib130","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.0000000000000383","article-title":"Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy","volume":"82","author":"Toledano","year":"2014","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.ajp.2024.104246_bib131","first-page":"81","article-title":"A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012","volume":"18","author":"Tolou-Ghamari","year":"2013","journal-title":"J. Res. Med. Sci."},{"issue":"2","key":"10.1016\/j.ajp.2024.104246_bib132","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","article-title":"Infections, inflammation and epilepsy","volume":"131","author":"Vezzani","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.ajp.2024.104246_bib133","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/YCT.0b013e31824d1d02","article-title":"Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder","volume":"28","author":"Wang","year":"2012","journal-title":"J. ECT"},{"key":"10.1016\/j.ajp.2024.104246_bib134","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2019.10.009","article-title":"Effects of diazepam and ketamine on pilocarpine-induced status epilepticus in mice","volume":"421","author":"Wang","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.ajp.2024.104246_bib135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.seizure.2016.11.030","article-title":"Epilepsy-associated genes","volume":"44","author":"Wang","year":"2017","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib136","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104246_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.831899","article-title":"The mediating roles of family resilience and social support in the relationship between illness severity and depressive symptoms among primary caregivers of children with epilepsy in China","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.ajp.2024.104246_bib138","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00023210-200115020-00005","article-title":"Oxcarbazepine: an update of its efficacy in the management of epilepsy","volume":"15","author":"Wellington","year":"2001","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.ajp.2024.104246_bib139","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/nedt.2006.2.3.269","article-title":"Zonisamide - a review of experience and use in partial seizures","volume":"2","author":"Wilfong","year":"2006","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.ajp.2024.104246_bib140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amj.2023.09.011","article-title":"Ketamine efficacy for management of status epilepticus: considerations for prehospital clinicians","volume":"43","author":"Williams","year":"2024","journal-title":"Air Med. J."},{"issue":"3","key":"10.1016\/j.ajp.2024.104246_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004768","article-title":"Inhibition as a binary switch for excitatory plasticity in pyramidal neurons","volume":"12","author":"Wilmes","year":"2016","journal-title":"PLoS Comput. Biol."},{"issue":"10","key":"10.1016\/j.ajp.2024.104246_bib142","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s40263-022-00954-w","article-title":"Eslicarbazepine acetate as adjunctive therapy for primary generalized tonic-clonic seizures in adults: a prospective observational study","volume":"36","author":"Winter","year":"2022","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.ajp.2024.104246_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109960","article-title":"Distinct regulation of tonic GABAergic inhibition by NMDA receptor subtypes","volume":"37","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.ajp.2024.104246_bib144","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/cns.13942","article-title":"Relationship between chronic hypoxia and seizure susceptibility","volume":"28","author":"Xu","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ajp.2024.104246_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107030","article-title":"Risk factors for depression in patients with epilepsy: a meta-analysis","volume":"106","author":"Yang","year":"2020","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.ajp.2024.104246_bib146","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/YCT.0000000000000132","article-title":"Post-electroconvulsive therapy recovery and reorientation time with methohexital and ketamine: a randomized, longitudinal, crossover design trial","volume":"31","author":"Yen","year":"2015","journal-title":"J ect"},{"issue":"7","key":"10.1016\/j.ajp.2024.104246_bib147","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.str.2018.05.004","article-title":"Glutamate and glycine binding to the NMDA receptor","volume":"26","author":"Yu","year":"2018","journal-title":"Structure"},{"issue":"6","key":"10.1016\/j.ajp.2024.104246_bib148","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1523\/JNEUROSCI.1316-22.2022","article-title":"NMDA REceptor Activation-dependent Antidepressant-relevant Behavioral and Synaptic Actions of Ketamine","volume":"43","author":"Zanos","year":"2023","journal-title":"J. Neurosci."},{"issue":"24","key":"10.1016\/j.ajp.2024.104246_bib149","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1113\/JP275169","article-title":"Altered NMDA receptor-evoked intracellular Ca(2+) dynamics in magnocellular neurosecretory neurons of hypertensive rats","volume":"595","author":"Zhang","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.ajp.2024.104246_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109219","article-title":"Arketamine, a new rapid-acting antidepressant: a historical review and future directions","volume":"218","author":"Zhang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ajp.2024.104246_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109305","article-title":"Ketamine and its metabolites: potential as novel treatments for depression","volume":"222","author":"Zhang","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ajp.2024.104246_bib152","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.934043","article-title":"Diazepam Monotherapy or Diazepam-Ketamine Dual Therapy at Different Time Points Terminates Seizures and Reduces Mortality in a Status Epilepticus Animal Model","volume":"27","author":"Zhou","year":"2021","journal-title":"Med Sci Monit"},{"issue":"44","key":"10.1016\/j.ajp.2024.104246_bib153","doi-asserted-by":"crossref","first-page":"11158","DOI":"10.1523\/JNEUROSCI.1547-16.2016","article-title":"Ketamine: NMDA receptors and beyond","volume":"36","author":"Zorumski","year":"2016","journal-title":"J. Neurosci."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201824003393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201824003393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T01:22:47Z","timestamp":1730510567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201824003393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":153,"alternative-id":["S1876201824003393"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2024.104246","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of ketamine in management of epilepsy: Clinical implications and mechanistic insights","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2024.104246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104246"}}